1 Center, M. M. et al. International variation in prostate cancer incidence and mortality rates. European urology61, 1079-1092, doi:10.1016/j.eururo.2012.02.054 (2012).
2 Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA: a cancer journal for clinicians65, 5-29, doi:10.3322/caac.21254 (2015).
3 Coffelt, S. B. et al. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. The American journal of pathology176, 1564-1576, doi:10.2353/ajpath.2010.090786 (2010).
4 Campbell, M. J. et al. The prognostic implications of macrophages expressing proliferating cell nuclear antigen in breast cancer depend on immune context. PloS one8, e79114, doi:10.1371/journal.pone.0079114 (2013).
5 Su, C. Y., Fu, X. L., Duan, W., Yu, P. W. & Zhao, Y. L. High density of CD68+ tumor-associated macrophages predicts a poor prognosis in gastric cancer mediated by IL-6 expression. Oncology letters15, 6217-6224, doi:10.3892/ol.2018.8119 (2018).
6 Gollapudi, K. et al. Association between tumor-associated macrophage infiltration, high grade prostate cancer, and biochemical recurrence after radical prostatectomy. American journal of cancer research3, 523-529 (2013).
7 Copeland, B. T. et al. Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer. Molecular imaging and biology21, 1054-1063, doi:10.1007/s11307-019-01318-5 (2019).
8 Nonomura, N. et al. Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer. BJU international107, 1918-1922, doi:10.1111/j.1464-410X.2010.09804.x (2011).
9 Murray, P. J. Nonresolving macrophage-mediated inflammation in malignancy. The FEBS journal285, 641-653, doi:10.1111/febs.14210 (2018).
10 Van Overmeire, E., Laoui, D., Keirsse, J., Van Ginderachter, J. A. & Sarukhan, A. Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues. Frontiers in immunology5, 127, doi:10.3389/fimmu.2014.00127 (2014).
11 Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell141, 39-51, doi:10.1016/j.cell.2010.03.014 (2010).
12 Wilson, H. M. SOCS Proteins in Macrophage Polarization and Function. Frontiers in immunology5, 357, doi:10.3389/fimmu.2014.00357 (2014).
13 Neuwirt, H. et al. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases. The American journal of pathology174, 1921-1930, doi:10.2353/ajpath.2009.080751 (2009).
14 Mansoori, B. et al. miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. Journal of cellular physiology234, 9816-9825, doi:10.1002/jcp.27670 (2019).
15 Muller, S. et al. IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors. Nucleic acids research46, 6285-6303, doi:10.1093/nar/gky229 (2018).
16 Lu, C. et al. miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood117, 4293-4303, doi:10.1182/blood-2010-12-322503 (2011).
17 Zhao, B. et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer letters342, 43-51, doi:10.1016/j.canlet.2013.08.030 (2014).
18 Wang, Y. et al. Genomic DNA copy-number alterations of the let-7 family in human cancers. PloS one7, e44399, doi:10.1371/journal.pone.0044399 (2012).
19 Kumar, M. et al. MicroRNA let-7 modulates the immune response to Mycobacterium tuberculosis infection via control of A20, an inhibitor of the NF-kappaB pathway. Cell host & microbe17, 345-356, doi:10.1016/j.chom.2015.01.007 (2015).
20 Wang, Z. et al. miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer. Scientific reports6, 25602, doi:10.1038/srep25602 (2016).
21 Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity41, 14-20, doi:10.1016/j.immuni.2014.06.008 (2014).
22 Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America101, 2999-3004, doi:10.1073/pnas.0307323101 (2004).
23 Kim, A., Saikia, P. & Nagy, L. E. miRNAs Involved in M1/M2 Hyperpolarization Are Clustered and Coordinately Expressed in Alcoholic Hepatitis. Frontiers in immunology10, 1295, doi:10.3389/fimmu.2019.01295 (2019).
24 Pobezinsky, L. A. & Wells, A. C. Let's fight cancer: let-7 is a tool to enhance antitumor immune responses. Future oncology14, 1141-1145, doi:10.2217/fon-2018-0037 (2018).
25 Xiao, G. et al. The Long Noncoding RNA TTTY15, Which Is Located on the Y Chromosome, Promotes Prostate Cancer Progression by Sponging let-7. European urology76, 315-326, doi:10.1016/j.eururo.2018.11.012 (2019).
26 Kang, M. et al. Concurrent treatment with simvastatin and NF-kappaB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-kappaB/LIN28/let-7 miRNA signaling pathway. PloS one12, e0184644, doi:10.1371/journal.pone.0184644 (2017).
27 Banerjee, S. et al. MicroRNA let-7c regulates macrophage polarization. Journal of immunology190, 6542-6549, doi:10.4049/jimmunol.1202496 (2013).
28 Linossi, E. M. & Nicholson, S. E. Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins. Immunological reviews266, 123-133, doi:10.1111/imr.12305 (2015).
29 Hu, J. et al. Suppressors of cytokine signalling (SOCS)-1 inhibits neuroinflammation by regulating ROS and TLR4 in BV2 cells. Inflammation research : official journal of the European Histamine Research Society ... [et al.], doi:10.1007/s00011-019-01289-x (2019).
30 McCormick, S. M., Gowda, N., Fang, J. X. & Heller, N. M. Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome. The Journal of biological chemistry291, 20574-20587, doi:10.1074/jbc.M116.746164 (2016).
31 Liau, N. P. D. et al. The molecular basis of JAK/STAT inhibition by SOCS1. Nature communications9, 1558, doi:10.1038/s41467-018-04013-1 (2018).
32 Liang, Y. B. et al. Downregulated SOCS1 expression activates the JAK1/STAT1 pathway and promotes polarization of macrophages into M1 type. Molecular medicine reports16, 6405-6411, doi:10.3892/mmr.2017.7384 (2017).
33 Yin, Z. et al. IL-6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Journal of cellular biochemistry119, 9419-9432, doi:10.1002/jcb.27259 (2018).
34 Maruoka, M., Kedashiro, S., Ueda, Y., Mizutani, K. & Takai, Y. Nectin-4 co-stimulates the prolactin receptor by interacting with SOCS1 and inhibiting its activity on the JAK2-STAT5a signaling pathway. The Journal of biological chemistry292, 6895-6909, doi:10.1074/jbc.M116.769091 (2017).
35 Recio, C. et al. Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice. Basic research in cardiology110, 8, doi:10.1007/s00395-014-0458-1 (2015).
36 Jacobsson, H. et al. Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways. Molecular oncology13, 1693-1705, doi:10.1002/1878-0261.12500 (2019).
37 Lv, R., Bao, Q. & Li, Y. Regulation of M1type and M2type macrophage polarization in RAW264.7 cells by Galectin9. Molecular medicine reports16, 9111-9119, doi:10.3892/mmr.2017.7719 (2017).
38 Dang, T. & Liou, G. Y. Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt. Scientific reports8, 7718, doi:10.1038/s41598-018-26143-8 (2018).